Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment

Per Nived, Tore Saxne, Pierre Geborek, Thomas Mandl, Lillemor Skattum, Meliha C. Kapetanovic

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences